Benitec Biopharma INC Form 4 insider transactions

NASDAQ

8 Mar 2024

BNTC

Form 4: Benitec Biopharma Executive Director Acquires 200,004 Stock Options

Megan Boston, Executive Director of Benitec Biopharma Inc., acquired 200,004 stock options on March 6, 2024, according to a Form 4 filing with the SEC.